IE44448B1 - Gonococcal pili processes for the preparation thereof and the use thereof - Google Patents

Gonococcal pili processes for the preparation thereof and the use thereof

Info

Publication number
IE44448B1
IE44448B1 IE864/76A IE86476A IE44448B1 IE 44448 B1 IE44448 B1 IE 44448B1 IE 864/76 A IE864/76 A IE 864/76A IE 86476 A IE86476 A IE 86476A IE 44448 B1 IE44448 B1 IE 44448B1
Authority
IE
Ireland
Prior art keywords
pili
atcc
gonorrhoeae
pittsburgh
pilus
Prior art date
Application number
IE864/76A
Other versions
IE44448L (en
Original Assignee
Bactex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bactex Inc filed Critical Bactex Inc
Publication of IE44448L publication Critical patent/IE44448L/en
Publication of IE44448B1 publication Critical patent/IE44448B1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/12Nitrate to nitrite reducing bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Pili from Neisseria gonorrhoeae are prepared by the artificial cultivation of N. gonorrhoeae bacteria and processing of the culture to isolate the pili. The pili which are obtained are capable of forming antibodies in the organism and can be used for serological and immunological purposes. For diagnosis in vitro, the pili are brought into contact with the serum to be investigated in the absence of any cell residues.

Description

The infection commonly known as Gonorrhea and caused by the organism Neisseria gonorrhoeae is a venereal disease which is extremely wide spread in the human population. The disease usually manifests itself by a visible discharge in 5 males but frequently is undetected and undetectable by external symptoms in females infected therewith. Heretofore, the only reliable mode of detection of infection has been by culturing discharges or mucus fluids believed to contain the organism. Such cultures take a period of more than one day to grow. Because of the social opprobrium attached to the disease and the reluctance of many persons infected therewith to return to the test clinic, it has long been desirable to provide a screening method which can give a reliable indication of possible infection or noninfection during a time for which it is reasonable to require the test subject to remain in the clinic.
Furthermore, heretofore there has been no development of any method of immunization against infection with i the organism of N, gonorrhoeae in humans. One of the 2o greatest problems associated with research in this area has been the fact that the organism only appears to infect humans and chimpanzees and, while there is a reasonable degree of correlation between results in chimpanzees and results in humans, such a correlation is not absolute.
Chimpanzees, although reasonably satisfactory as research models, are extremely expensive as research subjects. -244448 Four distinct colonial variants of Neisseria ► gonorrhoeae have been characterized. These four variants fall into two distinct categories. Variants Τχ and T2 produce experimental infection in human volunteers whereas Type T3 and T4 ere not known to cause infection. The first group may be distinguished from the second group in the observation that the first group possess filamentous structures on the surface of the colonial variants whereas the second group are devoid of these filamentous structures. These filaments are designated as Gonococcal pili (hereinafter G. C. pili).
In 1973 two papers were published purporting to show the isolation of Τχ and T2 pili from KL gonorrhoeae and further purporting to showthe formation of antibody response thereto (Buchanan, et al., J.Clin.Invest. 52, 2896-2909 (1973) and Punsalang and Sawyer, Infect.Immun. !3, 255-263 (1573)). See also Buchanan, et al., J.Clin.Invest. 51 17A (1972). The basic method utilized by Buchanan is acknowledged as Reference 41 in the 1973 paper as having been developed by Charles C.
Brinton, one of the inventors herein (C.C. Brinton, Trans.
N.Y. Acad, of Sci. 27, 1003 (1965)), as well as by Punsalang and Sawyer.
The Brinton method was developed for the study of the pili of E. coli. Applicants herein have attempted to repeat the work of Buchanan, et al. and have found that the procedures set forth therein to all intents and purposes do not yield pili of N. gonorrhoeae. A detailed study setting forth the comparison of the work of Buchanan with the work of Applicants as disclosed and claimed herein has been made and is being prepared for publication. -3It will be seen, from a comparison of the methods Utilized by Buchanan, et al as compared to the methods used by Applicants herein that Buchanan's methods and those of Punsalang and Sawyer are in fact excellently designed to remove GC pili from the product obtained by said procedure and that if perchance any immunological response to the alleged pilus material is achieved by Buchanan's product, this must be considered as being due either to artefacts or defects in the method as intended to be carried out.
The invention relates to the provision of purified pili of type and T2 Neisseria gonorrhoeae organisms as well as the TE subvariants thereof, if desired, in crystalline form.
The invention is based upon the discovery that these filamentary pili and materials derived from them by purification react immunologically with blood fluids and either indicate the presence of an infection or produce antibodies against such infection i.e. can act in principle either as a diagnostic agent or as a vaccine.
More specifically, according to one aspect of the invention there is provided a composition comprising pilic material derived from N. Gonorrhoeae,which is substantially free of cells or cell debris and which shows a strong agglutinative reaction against sera which themselves contain antibodies against at least one designated strain of N. Gonorrhoeae.
This specification also shows how the pili may yield a composition or material having two fractions, the major one being a phosphoglycoprotein of specified character and called pilin (the character depending on whether the pili were T^ and T2) and the minor fraction (6-8%) being another protein of somewhat higher molecular weight.
The purification of these fractions by various processes is described, and in particular an electrophoretic method of separation forms one aspect of the present invention.
The composition or material is crystallizable or crystalline and in the latter form is in this specification called GC pilus crystals; it has different solubilities in relation to pH changes according as it derives either from T^ and T^ type cultures but in either case shows the same immunological reaction as is mentioned above.
Therefore the invention is concerned additionally with a vaccine incorporating the pili devoid of cell material, or the pilin, in each case together with a pharmaceutically accepted medium.
Finally the invention provides diagnostic methods, performed in vitro, in which pili or material derived from them are used for determining (in effect) whether a blood fluid sample comes from a subject infected with gonorrhoeae, at least insofar as the antibodies derivedfrom infection by a strain of the same character as at least one of the designated strains.
GC pili are isolated from either surface culture or deep liquid culture of the corresponding organism. The methodsof surface and deep culture of N. gonorrhoeae cells are substantially conventional. In a modification of the deep culture method, a high surface area, reaction inert medium is added to the culture to aid in the purification.
A diatomaceous earth such as that known by the Trade Mark Celite has been found suitable.
In the case of the surface growth, the entire growth, that is to say, the cells and pili are removed from the - 5 44448 culture medium and suspended in an aqueous medium at a predetermined pH below 9.2. Where it is desired to isolate T2 pili only any pH above pH 5.5 and below pH 9.2 is suitable. Where it is desired to isolate T^ pili either per se or in the presence of T2 pili, a pH below pH 7.7 suitably around pH 7.0 is required. In the case of deep culture growth, such a suspending step is not necessary.
It has also been found that pilus crystals are soluble below 4.5 and are substantially reconstitutable when the pH is again raised above this provided it had not been reduced below about pH 2.5.
The portions of said suspensions which are soluble are then separated from the portions of the suspension which are insoluble. While filtration may be utilized for this separation it is generally preferred to utilize centrifugation. The supernate of the centrifugation (and the filtrate in the case of filtration) is discarded and the residues retained. In the next step of the purification procedure, the constituent portions of the Gonococcal pili are brought into solution and separated from the remaining material. In the case of the surface culture this material will include whole cells and debris and in the case of the deep culture, will additionally include the high surface area material such as the Celite.
Solution of the material of the gonococcal pilus crystals depends upon the breaking of inter pilus rod non-covalent bonds involving the peptide material which constitutes a major portion of the pili, while leaving the covalent bonds intact. That is to say, the use of a solubilizing agent is indicated which will not denature the peptide, but merely disaggregate the crystals into single pilus rods. The agents may be independent of pH such - 6 44448 being, for example salts, (suitably salts of alkali or alkaline earth metals and the anions of mineral acids) sufficient to raise the ionic strength above 0.5, preferably to between 4.0 and 5.0 and more preferably to about 4.4 urea to a concentration of between about 3M and about 5M, sufficient sucrose to raise the concentration above the 50% weight per volume and, finally water itself in a quantity sufficient to lower the ionic concentration below 0.002M.
The pilus crystals will, in a later stage of the process, be reprecipatated by (as appropriate) raising the ionic strength above about 0.05 by the addition of salts of mineral acid anions and alkaline earth metals; the addition of sufficient water to reduce the salt concentration below an ionic strength of 0.5, of sufficient buffer (suitably tris buffered saline) to provide a medium of ionic strength about 0.05 to about 0.5 at a pH of about 4.5 to about 9.2, or of sufficient water to reduce the sucrose concentration below 40% by weight respectively. The agents may alternatively be pH dependent such as basic buffers such as a tris buffer which will raise the pH to a level of from about pH 9.3 to about pH 11 for T2 pili or from about pH 7 to about pH 8.6 for T| pili the said range being determined by the commencement of solubility at the lower end and the commencement of danger of denaturation at the upper end. It has been observed however that even where the pilus structure is denatured by these or other methods to the extent that the pili will not recrystallize, their antigenic characteristics are apparently substantially unaffected.
After addition of the solvating medium to the solid residues mentioned above, the soluble and insoluble portion of said second suspension are again separated. As before, this separation may be by filtration or centrifugation, suitably 444 48 centrifugation, The centrifugation method may be either simple or modified. In the simple centrifugation method, the suspension is run in a low speed centrifuge, the supernate retained and the residue set aside. Where it is desired to raise the yield, the residue is re-suspended, re-centrifuged, the residue discarded, and the supernate combined with the immediately previous supernate. The combined supernates are then subjected to high speed centrifugation to remove the last traces of small debris in the residue and the supernate then set aside for use in the succeeding precipitation step.
In the modified form of the centrifugation process, the solubilized pili, that is to say, either those suspensions at elevated pH or those in an aqueous noncovalent bond breaking medium, such as urea, are mixed with aqueous caesium chloride. Since the caesium chloride gradient method involves centrifugation, complete separation of the debris is not necessary, however, a cleaner result is obtained by the use of either prefiltration or precentrifugation. The mixture in caesium chloride is then subjected to centrifugation in the conventional manner for caesium chloride separations and the absorption at various density gradient levels measured.
The location of the major peak, suitably measured at 280 nm indicates the location of the pilus solution.
Utilizing either of the methods of centrifugation, the aqueous fractions containing the pilus solutions are then treated in a manner conducive to the precipitation Of the pilus crystals. This may be done by the lowering of the pH where the pH has been raised, or by removal of the noncovalent bond breaking agent, the caesium chloride or, alternatively the addition of a precipitating agent such as ammonium sulfate. Precipitating conditions may be achieved either by dialysis or by direct addition.
Upon lowering of the pH and removal of the bond breaking agent, GC pilus crystals will form. The GC pilus crystals are then removed from the aqueous medium either by filtration, or, more suitably low speed centrifugation. The supernate is separated and the thus obtained GC pilus crystals are dried under reduped pressure, if desired, or stored in a suitable aqueous medium. While it is desirable to keep the crystals at reduced temperatures in a sterile medium, this does not appear to be essential for their stability in the absence of bacterial contamination.
It should be noted that the pilus crystals are in fact agglomerations of single pilus rods having a high molecular weight. Thus, where the medium containing the solubilized pili hae been purified by high speed centrifugation with, if desired, sterilization, through a Millipore (Trade Mark) (suitably circa 0,45 micron) filter, the individual pilus rods may be precipitated by ultra high speed centrifugation suitably above 40 KG.
It has also been found that where material of the very highest purity is not required, a convenient and rapid abbreviated purification proeess is quite satisfactory.
In this procedure the entire gonnococcal growth is transferred into a high pH buffer, suitably an ethanolamine buffer at a pH above the solution point of the variant (Tl or T2) in question preferably about pH 10.0 to ensure total .solution, the solids removed by filtration or centrifugation and the pH dropped - suitably but not essentially by dialysis. - 9 *44«° Indeed pH control to, say. pH 8.6 in the first instance will crystallize out T2 pilus crystals and a further drop to below pH 7.7, say to pH 7 will crystallize out T^ pilus crystals, thus indicating in one step the nature of the variant growth in question. This latter is merely confirmatory since a competent bacteriologist can differentiate between the two forms by inspection of their colonies.
Alternatively, pilus crystals may be precipitated by the addition of ammonium sulfate. An anionic concentration of between about 4% and 7% of saturation (at room temperature) will precipitate T2 pili as crystals, while T^ pili are precipitated by an anionic concentration between 51 and 10% by weight of saturation.
The GC pili have been subjected to SDS polyacrylamide gel electrophoresis and show a major and a minor band. The major band, about 92-94%, is designated GC pilin and comprises phosphoglycoprotein material. The minor band, about 6-8%, is a protein.
The T2 GC pilin has further been shown to comprise a peptide portion of 200 + 9 amino acids, between 2 and 3 phosphate groups, and between 1 and 2 hexose sugars, and is substantially soluble in aqueous media at a pH greater than 10.1 and substantially insoluble in aqueous media at a pH of less than 8.6 both pH's being measured at 20°C.
The major portion of T2 GC pili, namely T2 GC pilin has a molecular weight, as determined by SDS acrylamide gel electrophoresis of 21,500 + 1000 daltons.
The protein of the minor portion has a MW of about 28,000 daltons.
The GC pili isolated from type T^ N. gonorrhoeae growth appear to be extremely similar immunologically to those isolated from type T2 N. gonorrhoeae.
By comparison Type Tj GC pili are substantially soluble in aqueous media above about pH 8.5 and substantially insoluble in aqueous media at a pH of less than 7.7, both pH’s being measured at 20°C. Type GC pilin has a molecular weight of 22,000 + 1000 as determined by SDS acrylamide gel electrophoresis.
GC pili have been isolated from cultures of more than 20 different strains of N. gonorrhoeae. When injected into test animals GC pilus crystals as well as single rod pili and the eluate from SDS acrylamide gel electrophoresis will cause the formation of antibodies in the serum of the test animals, When GC pilus crystals are treated, either per se or in a suitable suspending medium, with serum containing anti15 bodies thereto, the crystals will agglutinate. This agglutination is readily observable most suitably in a dark field microscope but also by other means, and provides a simple and immediate test for the presence of the pilus antibodies in a test serum.
Among the uses of the test may be mentioned screening for gonnorhea to select individuals for culture testing, identification of high risk individuals distinguishing new, from old infections in a particular individual, identifying the strain responsible for a local epidemic and strains responsible for particular symptoms.
It should be noted that while this test is useful for the determination of the presence of antibodies to GC pili in a test sample, it is not possible to determine directly whether the subject from whom the serum was drawn has active gonorrhoeae or has been infected in the past and is merely a carrier of antibodies. It should be further noted that a very recently infected (i.e. in the previous 2 or 3 days) subject may not give a positive response since there may not have been sufficient time for the body to create a sufficient concentration of antibodies to give a desirable titre.
It has been noted that the pili of N, gonorrhoeae organisms contain one or more immunological determinants selected from a group of at least four such determinants.
Thus, the antibody agglutination reaction will occur between pili and a serum containing antibodies against at least one of such immunological determinants. The strength of the response will depend upon the concentration of antibodies in the test serum sample and equally the number of interacting immunological determinants on the pili and in the serum.
It is thus possible, given say, four different GC pilus samples known to contain at least one of the aforesaid determinants to rapidly test for the presence of the corresponding antibodies to GC pili in any test serum.
Similarly, where a source of organisms is available and may be readily cultured the pili from said organisms are isolatable. Since Standardized sera containing antibodies 'against any predetermined one of the four antigenic determinants of GC pili are available as a result of the present invention, (standardized, that is, from the point of view that they contain a standard predetermined component) said pili from the unknown test source are serotypable as to the identity and number of these determinants thereon. This procedure will greatly assist the the epidemiological work connected with infection tracking of Gonorrhea.
Pili may be absorbed on various carriers known to immunological testing such as latex, washed red blood cells, charcoal, polyacrylamide or agarose, to provide the substrates for serum or plasma agglutination tests.
The availability of pili also provides the basis for haonoagglutination and haarcagglutination inhibition tests. Both tests depend upon the principle that pili contain specific combining sites which will interact with red blood cells. Thus, where pili and blood cells are incubated together the red blood cells will give a diffuse agglutinated pellet by gravity settling. If no pili are present in the test medium the red blood cells settle to give a clearly defined pellet by gravity settling. This provides a means of testing for the presence of pili in a solution.
In the haanoagglutination inhibition test, a test serum believed to contain antibodies to GC pili is added to a solution .containing a predetermined quantity of pili and the mixture incubated and centrifuged. Pili interacting with antibodies thereto will be precipitated. The supernate is then added to red blood cells. When all the pili have been reacted with the antibodies in the test material, a sharp pellet (i.e. no agglutination) will result. It will be understood by those skilled in the art that such a test has significance when run against controls (i.e. no antibodies) and at predetermined dilutions. Ο®*® . · - The accuracy of this test is raised if the serum is first treated with washed red blood cells (i.e. prior to addition to pili). This procedure removes factors in the serum which would cause agglutination of the red blood cells regardless of the presence of pili.
Heretofore no mode of immunization against N. gonorrhoeae in humans has in any way been possible. It has been found, that when hitman volunteer subjects were injected with a sufficient quantity of GC pilus crystals, suitably of the order of from about 2 to about 100 micrograms per kilogram of body weight of said pili to raise the antibody level of their serum to a PAT (Pilus Agglutination Test) titer of at least 100, a degree of protection of at least 1.6 log cycles was obtained. That is to say, that the subject was able to resist infection by a counted number of organisms of the strain from which the injected GC pilus crystals were derived, of approximately 1.6 orders of magnitude greater than that required to bring about infection in control subjects in the un-immunized state. No toxic effects attributable to the pili have been observed from the injection of GC pilus crystals. Human subjects having a titer of up to 200 appear to be unaffected and the test primates (Rhesus monkeys) have been subjected to titer; levels of about 10,000 in the PAT Test without any ill effects whatsoever being noted. It has further been noted th&t it appears to be advisable that the injections of GC pilus crystals, in a suitable carrier medium, be made over a somewhat extended period suitably a period of up to about 5 weeks. Administration may be in between 1 to 5 aliquots of GC.pilus crystals,single rod pili, or any suitable source of G.C. pilin. A spreadout rate of administration while helpful is not essential. This rate of administration permits the gradual build-up of antibodies in the system.
It should further be noted that no local adverse reaction against the crystals at the point of injection has been noted in injections’in a subject to whom the crystals had already been administered at a previous point in time.
In view of the existence of several antibody determinants as mentioned hereinabove, it is desirable to administer pilus crystals, single rod pili or other sources of G.C. pilin containing each of the known determinants in order to obtain maximum protection.
Preparation of GC Pilus crystals Growth of N. gonorrhoeae Organisms Surface Culture Neisseria gonorrhoeae is found in four colonial 15 forms arbitrarily designated types Tp T2, T3 and T4. This designation however is generally accepted. Type Tj and T2 organisms are the causative organisms of the disease Gonorrhea in humans and only these forms possess pili. The procedures set forth below are applicable to the growth of type T-^ and type Tj organisms. It should be noted that strains of N. gonorrhoeae are isolatable from body secretions taken from human patients. 4444B Such secretions will usually contain not only the desired Tj or T2 types but also the unpiliated T3 and types.
Further, it should be noted that a culture which commences as, say, a fairly pure T2 type will in due course, upon subculture, produce nonpiliated T3 and T4 types as well as Tj types.
In the culture of Ti and T2 colonial variants a third piliated variant, arbitrarily designated TR is noted.
This variant has a rough appearance, and while it is not completely characterized, it is believed to be closely related to the Ti and T2 types as these types are yielded upon subculture of TR colonies. The yield of pili from TR types is the same as from T2 cultures.
In order to maximize production of either Tj or Ti pili, certain preliminary procedures should be followed.
The original samples are cultured on Thayer Martin (T-M) plates which allow the growth of N. gonorrhoeae inhibiting the growth of most other bacteria. Since T-M plates are not suitable for distinguishing colonial types, colonies from the T-M plates are streaked onto a suitable growth medium (GC medium,(Catalog No. 0289-1 Difco) for example). A succession of subcultures are then prepared from single colonies on the medium (hereinafter GC medium) until the colonies comprise greater than about 90% of the desired type. While the procedure may be employed equally well for type Ti as for type T2, and, as has been shown, type Ti and type Tj are immunologically similar, it is preferred to maintain separation of the types. Hereinbelow T2 will be discussed. Except where the differences are specifically noted, growth procedures for T2 are equally applicable to - 16 44448 Τχ. When the growth on a plate shows greater than 90% of, say, T2 colonies, the growth is removed from the plate and suspended in a suitable freezing medium,for example, BSAglutamine, divided into aliquots, and stored at reduced temperatures, suitably of the order of -70eC to -196°C.
It should be noted that, as stated heretofore, samples with an initially high proportion of T2 have a tendency, upon subcultures, to become unstable and yield lower amounts of T2· Hence, in growing the cultures, care must be taken on the one hand to ensure a high initial proportion of T2 organisms and on the other hand, care must be taken to utilize a sufficiently young strain, that is to say, one that has not been overly often subcultured, to guard against the occurrence of instability. Where it is desired to produce Τχ pili, it is even more important than in the T2 case to use an inoculum containing over 90% Τχ.
The inoculum for pilus production is prepared by streaking the primary, suitably but not necessarily, frozen, aliquots on a GC medium petri dish and incubating for between 12 and 24 hours. Twelve to 15 hours for strains with more unstable T2 types and 12 fo 24 hours for strains with more stable T2 types. It is preferred to grow the inoculum at a temperature of between 35° and 37°C, although 35eC is deemed preferable. High humidity conditions are also deemed desirable. At humidities of less than 70% the pilus yield has been noted to be lower than at higher humidities. It is therefore deemed desirable to operate at a humidity of between 70% and 90%. While the effect of the atmosphere of growth is incompletely understood, and older N. gonorrhoeae cultures will grow without the addition of carbon dioxide, an atmosphere of between 5 and 10% carbon « *3 » > —’ dioxide together with 90 to-95% air has been found highly suitable.
After the initial inoculation, the plate is covered with from about 50 to about 75% growth, the growth is removed therefrom. In a suitable procedure, a small amount of sterile casamino acids solution is added to the inoculum plate and the growth scraped off with a sterile glass spreader. It has been found suitable to utilize between 5 and 6 ml. of Solution per plate and from 2 to 3 ml. of the thus prepared suspension is sufficient to inoculate the larger growth pans of GC medium. The pans are then incubated for the same order of time under the same conditions as the inoculum petri dishes and the pili harvested therefrom.
At this point of the procedure it is no longer necessary to utilize sterile techniques although of course as in all procedures, it is desirable to use clean equipment, pure reagents, and to carry out all operations at as low a temperature as possible to inhibit undesired bacterial growth.
The gonococcal growth is harvested using a suitable buffer. While the chemical nature of the buffer is not critical, the pH range is important. For reasons which will become apparent, when purifying Tj pili the buffer may not be utilized at a range exceeding pH 9,3. It is preferred to operate in a pH range between 5.5 and 9.2, most suitably in a range of 7.0 to 8.6. Where a predominantly Ty culture has been employed the pH should not exceed 7.7, but should lie in the range of pH 5.5-7.5, suitably pH 7.0-7.2.
These, ranges will ensure the maintainence of all piliated material in the aggregated state. As the most suitable buffer, may be mentioned tris buffered saline.
In the preferred procedure the washing buffer is placed on the surface of the growth medium, the growth scraped off the medium with a suitable instrument, and the aqueous suspension removed in a suitable manner, for example, with a pipette or vacuum aspirator. If desired, a second washing may be carried out in the same manner and the liquid suspensions pooled.
In order to raise the yield a third washing may be carried out with a high pH buffer. That is to say, a buffer having a pH above 9.3, suitably between 10.1 and 10.3. The use of such a buffer will cause dissolution of all remaining pilio material. Where Tj pilus isolation is in view, the pH need only exceed about pH 8.6, but there is no disadvantage in the higher values. This basic suspension is not pooled with the first washes but held aside for a later stage of the purification. It should be noted that where there has been a good growth of pili, the growth has a characteristic orange/pink or warm pink color and the growth medium has an odor resembling cooking food. The growth is noted to be clumped together in Sticky ropey aggregates and slides easily off the growth medium when pushed with a suitable instrument, such as a glass spreader.
While the foregoing procedures are desirable where high yields of high-purity pili are in view, quite acceptable results are obtainable by a substantially abbreviated procedure. In this procedure the first and second wash procedures set forth above are not utilized. The entire growth is treated with substantially elevated pH buffer suitably an ethanolamine buffer in accordance with the procedures of the third washing. The wash medium will contain, in addition to the dissolved pili, many impurities otherwise removed, hpwever, it has been found that these impurities may be held in solution upon precipitation of the pilic material in the manner discussed below.
Deep Culture of N. gonorrhoeae Organisms The deep culture of the organisms of type T^ and T2 in liquid medium is carried out in a conventional manner utilizing a medium and environment identical to that used for the surface culture except that the medium does not contain agar as a solidifying agent. It has been noted that the organisms grow and shed pili continuously. Thus, a deep culture medium will contain much suspended pilic material.
Where type T2 cultures are being grown the pH, being normally below pH 9.3, there is no undesired solubilization of the pili. In the culture of T^ organisms the pH may rise above pH 7.7, hence prior to work-up as described hereinbelow, the pH should be adjusted down into the range of 5.5-7.7, preferably to about pH 7.0-pH 7.2. While it is not critical, it is preferred to make such an adjustment a few hours,say 8-20 hours before work-up to ensure crystallization of partially solubilized Ty pili.
In both Ty and T2 cultures, it is helpful, but by no means essential to carry out the growth in a mildly agitated medium in the presence of a small amount of diatomaceous earth such as Celite (Trade Mark). The amount of, say, Celite should suitably be between about 0.1 and about 0.5%, suitably about 0.3% by weight of the growth medium.
Purification of Pili Separation of pilus crystals from growth medium It should be noted that the wash from the surface growth of the N. gonorrhoeae organisms contains material soluble therein which is of no interest in the isolation of GC pilus crystals. Similarly, the same is true of the deep growth liquid cultures. In the case of the surface growth wash (first two washes only), the amount of liquid relative to the amount of growth is relatively small. It is preferred to centrifuge the entire wash material at relatively low speeds. The speed of centrifugation and the time of spin down are by no means critical. However, it has been found helpful to spin at between about 1000 G and 12,000 G (hereinafter written as 1 KG and 12 KG), for from about 5 to about 30 minutes, preferably at about 3 KG for from about 10 to about 15 minutes. The residue in the pellet contains both cellular, and pilic material, both of which are retained at this stage and the supernatant is discarded. The supernatant contains substantial amounts of impurities as well as small amounts of pili which are not worth recovering.
Where deep growth is the mode of the culture utilized, the volume of liquid is rather substantial and therefore centrifugation may be somewhat cumbersome. The use of a diatomaceous earth sandwich filter has been found useful in concentrating the growth from deep cultures. In this procedure a very coarse filter paper is laid on the filter pad, suitably a sintered glass or Buchner type surface, a layer of diatomaceous earth, suitably Celite of about 2 to about 5 mm thickness is charged thereon and covered with a second coarse filter paper. The Celite serves as the actual filtration - 21 medi-um while the upper filter paper serves merely to preserve the surface. The culture broth, havinq been checked for pH to ensure the pili are present in crystalline form is filtered through the filter pad and the filtrate discarded. The combined residues are then taken up in say, a high pH buffer similar to that utilized for the third wash of the surface growth culture, and this suspension is centrifuged at from about 1 KG to about 12 KG. It should be noted of course that in this case the pellet will contain the diatomaceous earth carrier and cell debris, and the pilie material will be in the supernate.
It is desirable at this point to separate the GC pilus material from the cell debris and, in the case of the deep growth culture, the diatomaceous earth as well.
.In the case of the surface culture pellet centrifuged from the low pH wash, this may be done by adding an aqueous medium which will break the noncovalent bonds between pilus rods in the system while leaving the covalent bonds intact thus dissolving the pilus crystals to give solubilized single rod pili. Such a medium may require raising the pH or may permit the pH to be unchanged. Where solubilization is to be carried out by pH change, there is added to the residue a suitable, moderately high pH buffer. It is desirable that the buffer have a pH of between 9.3 and 11, preferably between pH 10.0 and pH 10.4. With higher pH's there is a risk of denaturation of the peptides. This level of pH will solubilize Τχ and T2 pilus crystals.
Where . it is desired to separate Τχ from T2 pili in the original solid pellet, the pH of the buffer is initially provided to be greater than about pH 7.7 but less - 22 44448 than’about pH 9.3. The suspension is then centrifuged and the supernate therefrom can then be set aside or discarded according to the needs of the procedure. If the original solid pellet was believed to have contained substantial amounts of type T2 pili, fresh buffer of higher pH, namely above about pH 9.3 is added which will provide a solvent phase containing said T2 pili but free of type T^ pili.
The actual composition of the buffer utilized at this stage is not critical, however, a tris-saline buffer is especially preferred.
In both of the foregoing modifications, there is added to the total solids a volume of buffer approximately equal to 3 times the volume of the solids. Again, this amount is not critical but has been found to be sufficient to dissolve the pilic material without utilizing excessive volumes of the aqueous medium. If the pili are from a surface culture and said surface culture was subjected to a third stage high pH wash with a similar buffer, this wash may be added at this point. The pellet is then suspended in the aqueous medium. The method of bringing the pellet into suspension is not critical, short gentle sonication, long magnetic stirring, hand pipetting, hand mixing, vortexing or mechanical stirring may be used.
It has been found preferable to utilize mechanical stirring for a few seconds. While the mode of suspension is not critical, it is important that whatever mode is utilized the cells are not ruptured since cell rupture will introduce undesired material into the aqueous layer. The occurrence of cell rupture is noted as a layered pellet of pink above white in the subsequent centrifugation. The suspended material is - 23 then centrifuged. The manner of centrifugation is not critical, however, the conditions set forth above for the first centrifugation step have been found suitable. Filtration may be . used in place of centrifugation.
The dissolved pili are found in the supernate or filtrate from which they may be precipitated upon lowering of the pH. The degree of pH lowering will of course depend on whether type T^ or T2 pili are in process. Alternately precipitation may be achieved by adding sufficient ammonium salt, suitably a mineral acid salt such as the sulfate, preferably as an aqueous solution, to provide an ammonium sulfate, concentration of between about 4% saturation to about 10% saturation. However, in order to increase the yield and increase the degree of purity, it has been found desirable to introduce intermediate steps prior to the precipitation.
In carrying out these additional yield and purification steps, the supernatant and the pellet from the high pH centrifugation or filtration are both retained. The pellet from the high pH centrifugation stage is re-suspended, suitably in the same aqueous medium at the same pH in the same manner and the suspension centrifuged again in the same manner. After this centrifugation, the pellet is discarded and the supernates from both high pH centrifugations are combined and recentrifuged.
The purpose of the recentrifugation is to remove residual suspended impurities. Centrifugation is therefore carried out at a higher speed than heretofore. Speeds from - 24 44448 between 12 KG and 70 KG for from about 30 to about 60 minutes are operative. It is generally preferred however to spin at from about 27 KG to about 40 KG for about 60 minutes. The pellets are discarded and the supernate retained.
At this stage it is usually desirable to sterilize the pilus solution. This is required by certain FDA rules for certain purposes. Such sterilization may be readily achieved by passing the pilus solution, immediately before precipitation, through a Millipore filter, a 0.45 micron filter has been found especially suitable. Thereafter of course the materials must be handled in an aseptic manner, if it is desired to maintain sterility.
Under certain circumstances it may be desirable to isolate the pili in individual rod form rather than in crystal form. In this case the supernate is respun in an ultra high speed centrifuge at between 60 and 166, suitably 106 KG for between 2 and 4 hours, whereby the pili are pelleted in individual rod form.
The pili are re-precipitated by lowering the pH of the supernate to below 9.1. It has been found that the best results in terms of the nature of the crystalline material have been obtained by dialysis against a suitable low pH buffer. It has been found desirable to utilize a buffer having an initial pH of between 8.3 and 8.6,for T2 pili, while the chemical nature of the buffer is not critical, tris buffered saline has been found suitable. Dialysis is suitably carried out utilizing an excess of between about 30 and about 60 fold, suitably about, 40 fold. The dialysis is carried out with magnetic stirring of the external dialyzing medium for a period of from about 12 to about 18 hours. It is preferred to carry out the dialysis at a reduced temperature, that is to say, an ambient temperature of from about 0° to about 10°C, This lower temperature range lowers the incidence of undesired bacterial contamination.
It should also be noted that the buffer pH is temperature dependent. Hence, if the temperature of the buffer is measured after the system'has cooled down to its operating temperature, the pH may be found to have risen as high as pH 9.1. However,· satisfactory results are still obtained.
It should further be noted that it is not generally necessary to change the buffer where excess buffer in the range stated herein is utilized. The crystal suspension is then processed to separate the pilus crystals. Most suitably separation is carried out by moderate speed centrifugation. Centrifugation at from about 3 KG to about 8 KG for about 60 minutes has been found suitable. The supernate is then discarded.
Where it is desired to purify the pilus crystals further, the cycle of solution-high speed centrifugationdialysis-recentrifugation may be repeated two or three times.
If the pilus crystals are not to be utilized » 1 immediately, notwithstanding sterilization by.filtration, } the addition of preservative has been found helpful. It is desirable that the preservative be added not to the pilus crystals themselves or to a solution containing them, but rather to the dialysis buffer utilized to lower the pH of the solution. In the event that the added preservative is incompatible with the buffer, then, after crystallization of the pilus crystals has occurred, the incompatible buffer may be removed by dialysis against a compatible buffer and a further dialysis carried out utilizing the preservative plus the new buffer. . Among the preservatives that may be used are formaldehyde, merthiolate and azide. There are used between about 0.02 and about 0.05% of these preservatives.
Each of the named preservatives has certain detrimental effects. Formaldehyde causes cross-linking between the pilus rods. They may thus not be redissolved as before. Merthiolate has no cross-linking effect and the crystals may be reformed, however, such reformed crystals have a decreased ability to agglutinate in the presence of antibodies to the pili. Nevertheless, the antigenicity is not affected. That is to say, when injected into test subjects they cause the formation of apparently normal antibodies to the pili.
Azide is a very satisfactory preservative in that it affects neither crystal structure nor antigenicity nor agglutination. Unfortunately, it is toxic and cannot be employed where injection of the pilus crystals into human subjects is contemplated. The crystal preparation is suitably stored at low temperatures, i.e. at about 1°C to 4°C. However, where long storage is contemplated it is preferable to dissolve the crystals in an appropriate high pH buffer, filter through a Millipore filter and store in solution under sterile conditions. When the pili are required in crystalline form it is preferable to reconstitute them by lowering the pH to the appropriate crystallization value for Tj or T2 pili as the case may be. Both sterilization and a preservative can be employed when it is desired to achieve the best possible conditions of preservation.
Purification of Pili by Constant pH Dissolution The technique utilized to purify pili at constant pH is substantially similar to that utilized hereinabove using different pH levels.
As solubilizing agents there may be utilized aqueous solutions of, for example, salts, suitably salts of alkali, and alkaline earth metals with the anions of mineral acids, at an ionic strength above 0.5, suitably between about 4.0 and about 5.0, preferably about 4.4, urea at a concentration of between 3M and about 5M sucrose above a concenJ tration of 50% by weight and finally water itself where the ionic strength of the solution is reduced below 0.002 M, In one modification of this embodiment of the invention instead of suspending the first centrifugate pellet which comprises cells, pili, and debris, in a high pH medium, there is utilized in place thereof any of the foregoing agents in the environments aforesaid. The suspension is then low speed centrifuged as before. If higher yield is desired the supernate from the low speed centrifugation is set aside, pellets resuspended in a similar medium, recentrifuged and the thus produced supernate combined with the previous supernate and high speed centrifiuged. Pellets from high speed centrifugation are discarded and the supernate dialyzed against a suitable buffer to remove the solvating medium.
Thus, where solvating agent is a high concentration salt or sucrose, the ionic strength is reduced to below 0.5 for the salt and below 40% for the sucrose. In the case of urea·, the urea is dialyzed against a suitable buffer, say, tris buffered saline, to provide ionic strength of between .05 and 0.3 at pH 7.0 or pH 8.3, depending on whether Τχ or T2 pili are being processed, similarly when the solvating agent is water similar procedures are used to raise the ionic strength to at least 0.05.
The buffers utilized for this purpose are the same as the buffers utilized in the differential pH purification method and, moreover, are Utilized in the same manner.
Purification of GC Pili by Density Gradient Centrifugation Density gradient centrifugation is carried out by subjecting a mixture of pili and aqueous caesium chloride to centrifugation together and the optical density at a given wave length utilized to indicate the portion of the tube containing the pili.
While centrifugation may be carried out at a pH under pH 9, better results are obtained by carrying out the centrifugation in the pH range of 10.0 to 10.4, suitably at pH 10.1. In this procedure, the crude pellet containing cellular materials, pili, and debris, is suspended in a high pH buffer, as set forth hereinabove, and a suitable quantity of caesium chloride added thereto. For example, it has been found suitable to prepare a medium containing from about.2 to about 5 grams of dry caesium chloride per 10 ml. of aqueous medium. Thus, it has been found most suitable to utilize about 7.5 grams of caesium chloride to 20 ml. of aqueous medium.
The mixture is then, spun at from about 110 to about 250 KG, suitably about 200 KG for from about 30 to about 60 hours, suitably for about 42 hours and the optical density of fractions at a given point in the tube measured. Optical density measurements at 280 nm show a single peak. The density fractions under this peak are separated and dialyzed against a low pH buffer to form the pilus crystals in the same manner as that set forth hereinabove. The actual density range of the solution fractions collected at this point at 20°C is between 1.35 to 1.33 at pH 10.1.
PAT Test for N. Gonorrhoeae Antibodies The basic ability of GC pilus crystals or single pilus rods to agglutinate in the presence of antibodies to N. gonorrhoeae is the basis of the PAT Test. In this test, sera from the blood of subjects suspected of having been exposed to N, gonorrhoeae are mixed with GC pilus crystals or single pilus rods and the mixture observed for agglutination of the crystals or the rods.
In order for this test to be evaluated in its true light, three important factors must be considered. First, the test is not intended to replace the standard culture test but may serve as a screen to determine exposure to N. gonorrhoeae. The test will therefore show positive for both subjects who have had an aotive infection for more than a few days and also for subjects who have been exposed to the disease but have since .been cured. The third caveat is that .very recently infected subjects may not have developed enough antibodies to give a positive reading. Subjects showing a positive result in the test should be subject to the traditional culture test. It has been found as will be discussed further hereinbelow, that the pili of infectious forms of N, gonorrhoeae possess a number of specific immunologic determinants. Pili of certain strains will possess one or more of these determinants. Hence, for a screen to be effective, it must be carried out using pilus crystals which cover the spectrum of immunologic determinants.
The GC pilus crystals utilized in the test are prepared in the manner set forth hereinabove.
The test may be carried out using either serum or plasma from the test subject. References herein to serum or plasma therefore can be considered interchangeable for purposes of the test. The amount of serum or plasma required is extremely small. It has been found satisfactory to puncture the subject^ finger to obtain a few drops of blood and to spin these down in a small (circa 250 μΐ) centrifuge tube to yield between 10 and 20 fil of plasma which are adequate for carrying out the test.
It is customary to carry out tests of this nature at various levels of dilution. The serum is therefore diluted in predetermined (usually serial dilutions) with a predetermined suitable diluent. The nature of the diluent is not critical provided that it does not interfere with the operation Of the test. Any aqueous buffer such as phosphate buffered saline or tris buffered saline having a pH of between 7,0 and 7.5 may be utilized. Tris buffered saline having a pH of 7.2 is preferred. In the operation of the test, pilus suspension is added to the diluted serum to give a final concentration of between 10 and 50 micrograms per ml. of crystals in the suspension. It has been found that the best results are obtained at the lower concentration of pilus crystals, hence, for purposes of standardization of pilus antibody levels in test sera, the arbitrary concentration for comparison purposes of 20 micrograms of pilus crystals per ml. of diluted serum (or plasma) have been taken as the standard.
X0 After mixing the pilus crystals with the diluted sera, the mixture is incubated. The time of incubation is not critical and may be from as little as 15 minutes to as long as 48 hours with negligible change in the reading. In a rapid form of the PAT Test the serum-pilus mixture is agitated on X5 a slide by hand for 1 to 3 minutes, similar results are obtained but with some loss in sensitivity. The temperature at which the mixture is maintained is also not significant as long as it is maintained between 0° and about 45° except that it appears preferable to maintain the mixture at 2o a temperature of between 22°C and 40°C, suitably at about 22° for at least 15 minutes. Storage of the mixture thereafter at temperatures as low as 4°C for up to 24 hours do not appear to give significant changes of titer. Satisfactory results have been obtained by incubation for 30 minutes at 37°C.
At the expiration of the incubation period an aliquot is placed under a dark field microscope and the agglutination noted and scored. The scoring is done in the usual arbitrary relative way for tests of. this nature, namely, 4+, 3+, 2+, 1+, = + and In determining the titer of a given sample the last dilution which -gives a 1+ agglutination is taken as the final reading. - 32 44448 Thfe 1+ score is that score which shows the minimal noticeable agglutination over a standard control sample.
Since the titer readings may vary from batch to batch of pilus crystals according to their condition it is advisable to monitor the test, when carried out, by running the crystals against antisera of known PAT titer in addition to the usual controls against diluent without serum, and diluent with normal serum.
It has been found that under the conditions utilized, the test is reproduciable within a titer reading of a times 2 (X 2) factor.
Serotyping of N. Gonorrhoeae Heretofore, it has not been possible to serotype N. gonorrhoeae organisms into a useful and meaningful system.
It is not unusual for organisms of different strains of the same species to call forth different antibody responses.
These antibody responses characterize the strains and identification of these characteristics constitutes a substantial aid in epidemiological studies of the progress and origin of a particular outbreak of the disease. It is particularly of interest in the venereal diseases since the elimination of the disease very often depends upon personto-person contact tracking. Thus, if the source of an infection can be identified by serotyping, this type of tracking can be greatly assisted.
It has been found that by examination of 21 strains derived from sources well distributed throughout the United States that there are at least four (4) immunological determinants present in the pili of these strains. One or more of these determinants are present in each strain. Hence, if the determinant characteristics of a particular sample can be identified the origin of the infection can be more readily discovered.
Where N, gonorrhoeae organisms are derived from an infected subject and grown to produce pilus crystals the immunologic determinants present in the pilus crystals from the subject may be readily discovered by subjecting them to the PAT Test with -the aforementioned typing sera which are known to contain antibodies for but one determinant. Thus, the serological profile of any given sample organism may be established.
Gonorrhoeae Vaccine - Safety and Potency G. C. Pilus crystals and single rod pili have been injected into test subjects in vivo and found to have no toxic effect whatsoever. The only negative effects were noted with intravenously injected chick embryos- Test rabbits were given three (3) injections subcutaneously of 100 to 200 micrograms per Kg, giving a total dosage of 300 to 600 micrograms per Kg, rats were similarly injected two (2) times at 8,000 micrograms‘per Kg, giving a total dosage of 16,000 micrograms per Kg. Rhesus monkeys received three (3) injections of 100 micrograms per Kg intramuscularly, and humans received injections of 2-10 micrograms per Kg, followed by one injection of 50 micrograms per Kg intramuscularly. None of the test animals died nor showed any local or systemic toxic effects, the chick embryos showed an LD-50 of 60 micrograms per pound. The reactions in human subjects varied from no systemic effects whatsoever to transient chills and fever in one of the subjects tested. The PAT titer in rabbits reached 1,000 to 8,000, and in Rhesus monkeys reached I’O,000+. The PAT titer in humans varied between 100 and 200.
The dose required to infect 50% of test subjects (IDjq) is of the order of 5.0 x 10^ organisms. Preliminary experiments indicate that the ID^q of a human subject having a PAT titer of 100-200 is 2.0 X 104 organisms. This represents 1.6 log cycles of protection, or stated another way, a human subject having a PAT titer of 100-200 has only about a 0.86% chance of being infected after 1 contact whereas an unimmunized person runs about a 30% risk.
In view of these findings, in order to provide an acceptable level of protection in humans, the human subject should have administered a sufficient quantity of GC pilus crystals suitably against all known determinant factors to raise the PAT level against each of these determinants to at least 100, preferably to at least 200, Such levels are obtainable by administering between from about 2 to about 100 micrograms per kilogram body weight of GC pilus crystals of each determinant. It should be noted however, that a titre of 100 is achievable with as little as 1 pg/Kg. The mode of administration will depend upon the sensitivity, if any, of the subject, but may suitably be administered in between 1 and 5 doses over a time period of up to 8 weeks.
The GC pilus crystals, single pilus rods, or other sources of GC pilin may be administered in any suitable medium for intramuscular injection. 4 δ « * θ EXPERIMENTAL Sources of N. Gonorrhoeae Utilized strains of N. gonorrhoeae were isolated from humans with Gonorrhoeae and are designated as follows: Pittsburgh 1-2 CDC M-2 Seattle 1-2 Pittsburgh 3-2 CDC T-2 Seattle 3-2 Pittsburgh 4-2 CDC F62-2 Seattle 9-2 Pittsburgh 6-2 Atlanta 4-2 Norfolk 2-2 Pittsburgh 7-2 Atlanta 6-2 Norfolk 7-2 CDC B-2 Atlanta 9-2 Dayton 8-2 CDC C-2 Atlanta 10-2 CDC 005- -2 In the following process example, specific reference is made to the Pittsburgh 3-2 strain. Iihen the other named organisms are subjected to the same procedures, as the Pittsburgh 3-2 strain, similar results are obtained.
EXAMPLE; STEP I Strain Purification The primary cultures of the Pittsburgh 3-2 strain were plated out on Thayer-Martin plates containing ThayerMartin Agar {Manual of Clinical Microbiology, 2nd. Ed., Amer. Soc. Microbiol, Lenette, et al. (Ed.) 1974, p. 920). The plates are incubated for about 18 hours at 35®C in a humidity of 90% in an atmosphere comprising 95% air and 5% carbon dioxide. The plates are inspected and colonies resembling the highly piliated T^ form are re-streaked on GC medium. After incubation-under the above conditions the T2 type colonies are picked and restreaked again on GC medium.
In accordance with the above procedure, but where the culture of the type of this organism is desired colonies having a preponderance of the less piliated Tj_ type are similarly restreaked.
EXAMPLE; STEP II Preparation of GC Growth Medium a) Preparation of PSF Supplement An aqueous solution of cocarboxylase (0.2% by weight) in distilled water is prepared at ambient temperature and sterilized by filtration through a 0.45 micron illipore filter. An aqueous solution comprising glucose (40 g.), glutamine (1.0 g.), ferric nitrate (0.5% by weight, 10 ml. in distilled water), and distilled water (90 ml.) are heated in an autoclave at 121°C with 16 psi pressure for 10 minutes and the solution cooled. To this autoclaved solution is added 1 ml. of the previously prepared cocarboxylase solution to provide the DSF solution. b) Preparation of Growth Medium Bacto GC Medium Base (Difco Mannual 19th. Ed., p. 122) (Difco Laboratories, Detroit, Michigan) (10.8 g.) and distilled water (300 ml.) are gently agitated in a suitable container and the mixture in the container autoclaved at 121°C with 16 psi pressure for 15 minutes. The container is removed from the autoclave, cooled to between 50°C and 60°C and the DSF supplement, prepared as above, (3 ml.) is added thereto.
« » Preparation of Inoculum Plates and Growth Dishes Pyrex (Registered Trade Mark) or aluminum growth dishes and petri type inoculum dishes are washed, rinsed in distilled water, covered with aluminum foil, and autoclaved for 30 minutes at 121°C with 16 psi pressure. Into the thus prepared dishes is poured the molten growth medium prepared as above in Example II. The plates should be poured with care in a closed dust free room utilizing aseptic techniques to prevent contamination with undesired bacteria.
EXAMPLE; -STEP III Growth of Inoculum The T-2 colonies from the Thayer-Martin plates (Example I) were re-streaked on inoculum plates prepared as above and cultured at 35°,90% humidity, in an atmosphere of % carbon dioxide and 95% air. The plates are progressively subcultured until more than 90% of the growth is the piliated Tj colonial type. Depending upon the stability of the strain the growth time is between 12 and 24 hours, at which time the plate will be covered with between 50% and 75% of growth.
EXAMPLE; STEP IVA Production of GC Pili by Surface Culture The petri dishes of growth are washed with aqueous 0.7% by weight). The growth is Step III containing the T2 casamino aoid solution (5 ml, scraped off. the medium with a -44448 sterile glass spreader, the suspension of the growth in the casamino acid solution is pipetted from the plate and divided between two (2) growth pans ca. (14 X 10 in). Said pans having been prepared in the manner set forth above.
The suspension is spread evenly over the surface and the pans incubated at 35°C, 90% humidity, in 5% carbon dioxide plus 95% air atmosphere for 20 hours.
Harvesting of Surface Culture Growth A stock solution of tris buffered saline is pre10 pared by dissolving sodium chloride (510 g.), tris, also known as tris(hydroxymethyl)amincmethane (363 g.) and concentrated hydrochloric acid (100 ml.), together with distilled water sufficient to produce a stock solution having a volume of 10 liters. The pH is adjusted to a standard working pH of pH S.5 by the addition of more concentrated hydrochloric acid. Where an upward pH adjustment is required, concentrated (10 N) aqueous sodium hydroxide is added. Prior tc use the stock solution is diluted to 1/6 of the original concentration. The tris buffered saline (hereinafter TBS) has an initial pH of 8.5. 10 ml. of the TBS solution is placed on the growth surface of the production pan, the growth scraped off with a glass scraper and the suspension pipetted off into a reservoir. The washing and scraping is repeated with a second batch of TBS (10 ml.)’, and both washings pooled. The growth surface is washed a third time with ethanolamine buffer (10 ml., pH 10.1) and the suspension retained but not pooled. (The ethanolamine buffer is prepared from liquid ethanolamine, 37.3 ml., aqueous hydrochloric acid, 1 N, 147.0 ml. and distilled water to 1 liter).
In accordance with the above procedure, where T^ rather than T2 pili are being cultured the pH of the TBS is between pH 7.0 and 7.2.
In a good production run the growth has a character5 istic orange/pink or warm pink color and an odor resembling cooking food. The growth clumps together in sticky ropy aggregates and slides readily off the agar surface of the medium when pushed with a glass spreader.
The.pans containing the growth medium are then 10 cleaned, washed and sterilized in the manner set forth above, and recharged with more growth medium.
EXAMPLE ; . STEP 1VB Deep Culture Growth of G. C. Pili In accordance with the procedures of Step IVA using the same growth medium and nutrient supplement but excluding the agar and substituting soluble starch for the insoluble starch, inoculum is charged to the growth medium and incubated in an atmosphere of 95% air and 5% C02 at 35-37°C in the presence of up to 0.5% (based on volume of liquid medium) of Celite, for 18 hours under gentle agitation.
The culture medium is then filtered through a sandwich filter pad on a coarse sintered glass funnel. The filter pad comprises a coarse filter paper, a 5 mm layer of Celite and a further coarse filter paper.
The filtrate is discarded and the residue treated 4*44S in accordance with the third (ethanolamine buffer) wash procedure of Step IVA-, which is then processed in accordance with the procedures of Step V , paragraph iii, infra et seg.
EXAMPLE: STEP V Separation of Pili from Cells and Debris i) The TBS suspensions produced in the foregoing Steps are charged to centrifuge tubes (volume of the tubes depending on the number of production runs combined) and centrifuged for 15 minutes at 3 KG. The supernatant is discarded and the pellet retained. ii) To the pellet is added the ethanolamine suspension from the third wash of the growth pan and additional ethanolamine buffer at pH 10.1 to a volume approximately 3 times the observed pellet volume in the centrifuge tube. The liquid layer is stirred rapidly for 5 seconds with a mechanical stirrer to bring the soluble portion of pelleted material into suspension. iii) The suspension is then centrifuged for 15 minutes at 3 KG the supernate decanted from the pellet and preserved. The pellet is then resuspended in 3 times its volume of ethanolamine buffer pH 10.1 as hereinabove, and recentrifuged for 15 minutes at 3 KG. The supernate is decanted and pooled with the ethanolamine buffer supernate from the immediately prior step and the pellet discarded.
The coinbined ethanolamine buffer supernates are centrifuged at 31 KG for 60 minutes. The supernate is decanted and preserved and the pellet discarded.
EXAMPLE ; STEP VI Crystallization’ of GC Pili Preparation of Dialysis Tubing and Tris Buffered Saline A roll of dialysis tubing (100 foot, Fisher Scientific Catalog Number 8-677 B) is boiled sequentially in a) distilled water (2X, 4 liters each time), b) aqueous sodium bicarbonate (2X, distilled water, 4 liters, containing sodium bicarbonate 2 teaspoons each wash), c) aqueous disodium ethylene diamine tetraacetate (2X, distilled water, liters, Na EDTA 2 teaspoons; each time), d) aqueous ethanol (2X, ethanol/water, 1:1, 4 liters; each time), e) distilled water (2X, 4 liters, each time). The dialysis tubing is then stored in distilled water containing a trace of benzoic acid (distilled water 4 liters, benzoic acid 1 teaspoon). Tris buffered saline stock (TBS) prepared in accordance with Step IV is diluted with distilled water to provide the dialysis solution (166 ml. stock solution diluted to 1 liter with distilled water).
Dialysis of GC Pili Solution 100 ml.,of ethanolamine buffer containing GC Pili in solution as produced in the foregoing Examples are dialyzed against 4 liters of TBS (pH 3,5 measured at 20 ®C) utilizing dialysis tubing prepared as above and utilizing diluted TBS as prepared above. The dialysis is carried out in a cold room (ambient temperature circa 4°C). The external dialysis buffer.solution is stirred magnetically. Dialysis is carried out for 18 hours. A rise to pH circa 8.7 in the dialysis medium is noted, A cloudy blue/white birefringent precipitate of GC pilus crystals is formed at the end of the dialysis period. The thus precipitated material is centrifuged at 7.5 Krpm for 60 minutes and the supernatant discarded to leave GC pilus crystals of Pittsburgh strain 3-2 N. gonorrhoeae as the pellet.
In accordance with the above procedures, but where Tj rather than T2 pili are to be isolated, the initial pH of the TBS is pH 7.0-7.2.
EXAMPLE: STEP VII Further Purification of Pili The pellet of Step VI is suspended in approximately 30 times its volume of ethanolamine buffer (pH 10.1). The- tubes swirled gently to dissolve the pellet and the suspension centrifuged for 60 minutes at 31 KG.
The supernate is decanted off and the pellet discarded. The supernate is dialyzed against TBS in accordance with the procedure of . Step VI , and the thus obtained crystalline material isolated by centrifugation also in accordance with the procedures of Step VI . The pellet is once more resuspended in ethanolamine in accordance with the foregoing procedures, filtered through a 0.45 micron filter if sterilization is desired and similarly recentrifuged and redialyzed as heretofore, and, similarly, isolated by centrifugation.
In accordance with the foregoing procedures, where the thus formed GC pilus crystals are to be stored for a moderate period'of time, a preservative is added to the dialyzing TBS solution where the preservative is compatible therewith. Compatible preservatives which may be utilized in accordance with this procedure are 0.05% weight per volume of neutral aqueous formaldehyde, 0.01% weight per volume merthiolate or 0.02% weight per volume sodium azide.
In accordance with the foregoing procedure where the preservative is not compatible with TBS after the Pili have crystallized, the tris buffer is removed by dialysis against saline (0.15 M aqueous sodium chloride, hours). The preservative is added to a fresh batch of said saline, and dialyzed against the suspension of GC pilus crystals for 18 hours. The crystals are stored in this medium at 40°C. Alternatively the medium containing the crystals may be frozen and stored at -70°C.
Yield The yield of GC pilus crystals from the strains of N. gonorrhoeae listed in Step I, where the inocula contain at least 90% T2 colonial types, lies in the range of 5 to 15 micrograms/square centimeter of growth surface.
Similar but slightly lower yields are obtained from T^ colonial types.
EXAMPLE; STEP VII; ALTERNATIVE TO V Caesium Chloride Density Gradient Isolation of GC Pili ml. of the TBS (pH 8.5) wash containing GC pilus crystal suspension‘from Step IV is diluted to 20 ml. with tris pH 8.5 buffer, the pH adjusted to pH 10.1 by the addition of aqueous sodiuin hydroxide (O.IN) and 7.5 grams of dry caesium chloride added thereto. .The solution is spun at 200 KG in the SW41 Rotor of a Beckman (Trade Mark) L-265 Centrifuge for 42 hours. Fractions are collected from the tube and the optical density at 280 nm and the refractive index for each sample measured. The refractive index is related to caesium chloride density to whioh the refractive index readings are converted. The fraction number is plotted on the X axis against solution density on one Y axis and optical density on a second Y axis.
A single principal peak corresponding to the GC pili is located at φ equals 1.3422 + .0038. The fractions whose ξ equals 1.35 to 1.33 are combined and dialyzed and purified to yield GC pilus crystals in accordance with the procedures of Steps VI and VII.
EXAMPLE’STEP IX Gel Electrophoresis (Method of Ornstein 1962 - Distillation of GC Pili to yield GC Pilin. and Davis - Disc Electrophoresis Products Industries, Rochester, N.Y.) Standard cylinders of 10% acrylamide gel (9.7% acrylamide and 0.3% Ν,Ν'-methylene-bis-acrylamide are polymerized with TEMED) and ammonium persulfate were prepared and set up between gel and reservoir buffers comprising tris hydrochloride at pH 8.0 and 0.1% SDS, The upper gel surface was loaded with a charge comprising 50 micrograms of Tj pilus crystals, 20 ug of Clelands Reagent (0.01M) 1 mg. Of SDS 20 λ (Microlitres) of glyool and 20 λ (Microlitres) of Bromophenol Blue (0.002%). Prior to charge the pili were heated with the SDS and the Cleland’s reagent for 2 minutes at 100°C.
The electrophoresis was run at 5 ma (at ca. 170 v) until the Bromophenol Blue had run 6 cm. The gels were removed and cut 'through the dye band and two gels stained with Coomassie Blue Stain (0.2%) to give two bands - a major band and a minor band.
The unstained gels were frozen and bands corresponding in position to the stained bands were cut out.
The major band was extracted with reservoir buffer at 37°C in a rotator for 24 hours, the buffer drawn off and evaporated almost to dryness. A rerun of the product yielded a single band of the same Rf value.
This material is designated GC pilin.
Antigenicity Test Of G.C. Pilin The gel containing the major band was homogenized with about 10 ml. of saline and injected into three test rabbits subcutaneously. Test animals Pj and P-j-j received 3.1 ml suspension and Pjj]- only 2 ml. of the suspension.
Second and third injections were made about 15 and about 30 days later. The materials of the second and third injections were prepared by extracting the major protein into reservoir buffer (0.8 ml.) at 37°C for 24 hours. The extracted buffer was then combined with an equal volume of Freund's Incomplete adjuvant and one-third of each mixture injected into each rabbit.
One week after the last injection all rabbits showed titres exceeding 1000 in the PAT Test against Pittsburgh 3-2 Type T2 pili as shown in the Table below.
PCA TEST USING 50 γ/ml 3-2 PILI PreImmune Rabbit PI PI PI PII PII PII PIII PIII PIII Rabbit Bled;Day# 1 15 29 1 15 29 1 15 29 -204 Test „ Dune 16 16 35 16 16 35 16 16 35 35 Dilution 1/2 + +/++ 3+ 3+ 3+ 4+ + ++ 3+ 0 1/4 + + 3+ 3+ 5+ 5+ 0 3+ 3+ 0 1/8 0 + 3+ 3+ 5+ 5+ 0 3+ 4+ 0 1/16 0 0 3+ 3+ 5+ 4+ 0 ++ 4+ 0 1/32 0 0 3+ + 4+ 4+ 0 + 4+ 0 1/64 0 0 + 0 4+ 3+ 0 0 0 0 1/128 0 0 + 0 4+ 3+ 0 0 ++ 0 1/256 + •3+ + 0 1/512 + ++ + 0 1/1024 + ++ + 0 1/2048 0 + + 0 1/4096 0 + 0 0 end point <2 4 1024 32 > 128 >4096 42 16 2048 <2 ' Slab gel electrophoresis against myoglobin, chymotrypsinogen and human gamma globulin give the major fraction a M.W. of 20,500 to 21,500 and the minor protein a M.W. of about 28,000.
Carbohydrate Analysis - Phenol-sulfuric Acid Test A standard curve was prepared by treating stock glucose solution with 0.1N aqueous sodium hydroxide and measuring the UV absorption at 485 nm. Runs on the Pittsburgh 3-2 pili and the CDC B-2 pili indicates sub10 stantially the same amount of carbohydrate content, namely, 1,49 + 0.56% corresponding to 1-2 hexose residues per protein subunit.
Phosphorus Analysis (Method of Chen, et al, Anal.Chem, 28 1756 (1956)) The pili were digested in sulfuric acid and .assayed against a potassium dihydrogen phosphate solution in water by the ammonium molybdate-ascorbic acid assay. The mean value for the Pittsburgh 3-2 pilus strains was 0.332 + 0.026% and for the CDC B-2 strain pili, 0.366 + 0.048%, indicating 2.5 and 2.3 phosphorus atoms per protein subunit respectively.
Amino Acid Analysis of Type T2 Pilus Crystals (Modified method of Spackman et al, Anal. Chem. 30, 1130 (1958)).
The analysis was run on a Beckman Spinco Model 120B Amino Acid Analyzer utilizing as internal standard norleucine and 2-amino-3-guanidino propionic acid. The protein sample (10 mg.) was hydrolyzed with concentrated hydrochloric acid at elevated temperatures (6N, 110°C), for 24 hours in evacuated vials (0.025 mm.Hg.) Tryptophan analysis was estimated by the spectral method of Bence et al (Anal. Chem. 29, 1193, (1957)). aspartic + asparagine 26 isoleucine 9 alanine 23 arginine 8 glutamic + glutamine 21 tyrosine 7 lysine 20 proline 6 glycine 17 tryptophan 4-5 valine 17 histidine 3 serine 14 1/2 cystine 2 leucine 12 methionine 2 threonine 9 phenylalanine 2 Number of amino acids - 200 + 9, m.w. 21, 500 + 1000 daltons Physical Properties Solubility Pilus crystals, appearing in an electron microscope as bundles of pilus rods, exist in the crystalline state about pH 5.5 and about pH 9.3. The crystals from T2 variants start to separate into single pilus rods between pH 9.3 and pH 10.1. Above pH 10.1 uhey exist as single pilus rods. Similarly, the crystals of Ty pili start to separate into single pilus rods at pH 7.7 and exist as rods above pH 8.6- i.e. the -rystals are entirely disaggregated. Above about pH 11,0 T2 pilus rods disassemble into smaller oligomeric units with a sedimentation constant of about 5.5.
The pilus crystals are soluble at pH 8.5 in 4 M. aqueous sodium chloride, 50% aqueous sucrose and 20% saturated aqueous calcium chloride (both by Weight). The crystals are also soluble in urea at 3 M and above.
However, treatment with urea at 3.5 M or greater for more than 2 days leads to denaturation of the GC pili.
Ultracentrifugation A GC pilus preparation (1 mg./ml.) was prepared in ethanolamine buffer (0.147 ionic strength, pH 10.1).
The solution was run at 20 Krpm in a Beckman Spinco Model E Ultracentrif-uge using an AN-D Rotor. Uncorrected sedimentation rate S equals 37 sVedbergs.
Pilus Rod Dimensions GC pilus crystals were taken up in ethanolamine buffer at pH 10.0 with stacked disc rods of TMV protein negatively stained and examined in an electron microscope. The average diameter of GC pili is 83.4 + 2.3 A.
PAT Test Pilus crystals are suspended in TBS at pH 7.0 at a concentration of between 30 to 60 ug/ml. Non cloudy test serum is utilized.' Where the test serum is cloudy it is centrifuged at 30 KG fcr 30 minutes and the supernate utilized. Serial dilutions cf the serum are prepared and 0.025 ml. of the serum samples and 0.025 ml. of pilus crystal suspension are each charged to each micro titre plate well and the mixture agitated for 30 minutes at ambient temperature. The wells are then read for crystal clumping in a dark field microscope.
The wells are then scored on the basis of maximum dilution which gives crystal agglutination observably greater than control.
Sample Test White, New Zealand, female rabbits weighing from 4 to 6 pounds were injected subcutaneously with purified pilus preparations from CDCM-2, Pittsburgh 3-2, CDCT-2, CDC005-2 and Pittsburgh 4-2 strains, mixed 1:1 with Freund's Incomplete adjuvant and emulsified by syringing the mixture. About 100 to 200 pg/Kg. of pili was given in 3 injections about 2 weeks apart and the rabbits were bled 1 to 2 weeks after the 3rd injection. The blood was allowed to clot and the serum removed in the usual manner.
The first 3 test sera were then run against pili from 21 N, gonorrhoeae strains and the results set forth in the Table below. Experimental errors normal and expected in this type of work are as large as a factor of 4 or 5; hence apparent inconsistencies between the Tables. ' ϋ 5; It·’ * iZ Atlanta 10-2 CM Cl CM cn Seattle 3-2 CM m vO Seattle 1-2 tO rH «Ο ι—1 . mt Ό »U aj C CM m I rH CP» < CO 00 CM m Atlanta 6-2 OO V MJ- to o* Atlanta 4-2 tD rH 16 CM O CM Q I U H CO 03 V 512 CDC M-2 1 12β! I CO *Λ> CDC C-2 CM m OJ V CM m L> CM O I u Pi co CM rH LQ σ'» A HO w A CM ω t ~ tO aj •H Cu - tO Jr I— Pittsburgh 4-2 to rH CO Pittsburgh 1-2 ϊ 256 to rH to i-i Pittsburgh 3-2 j M3 . rHh' 256 1 C / tn ή Z 3 <0 / rH U / rt ta / (L CO Z /ε c /2 3 Ή / rH M tf •rt QJ JH CM f s o c u Pittsburgh 3-2 j CM I 1 u Q O r fu ω 4J w < CM 1 U tn ο σ u o •X to 0 AJ iM m 128 MP. to ! Seattle j 9-2 to rH 128 to rH c V AJ CM £*» 1 Π3 CO • ft to _ rH MJ* to Not folk 7-2 CO to rH co Norfolk 2-2 Mf to CM cn A OO Jj 3 ja cm w 1 u r* XJ CL tO j 128 M? M. Pilus Strain Pilus x. Serum "M. Strain cM Λ xZ CJ Q U Pittsburgh 3-2 CM . r K O Q υ *005 is a CDC strain isolated from a patient with disseminated GC infection.
In accordance with che above procedure a 7 x 7 serotype pilus agglutination test was run using the pili and the sera derived frcm seven designated strains. For ease of interpretation of the results set forth in Table la below, the cross reaction readings (pili against sera of the same strain) are normalized to 100 and the other readings adjusted accordingly.
TABLE la Serum Strain Pilus Strain Pitts- burgh 3-2 Pitts- . burgh 4-2 CDC a-2 CDC T-2 CDC 339-2 CDC C-2 Norfolk 2-2 Pittsburgh 3-2 100 3.1 8.3 0.17 1.6 <0.008 0.52 Pittsburgh 4-2 0.16 100 <4.2 0.0S6 0.20 40.008 0.065 CDC M-2 < 0.039 40.024 100 40.02 0.20 0.13 0.016 CDC T-2 <-0.31 40.024 44.2 100 0.20 40.008 i 0.032 CDC 339-2 2.5 40.024 4.2 40.02 100 0.016 0.260 CDC C-2 <0.003i <0.78 44.2 0.17 40.10 loo I 0.065 Norfolk 2-2 <0.31 0.78 <4.2 0.04 0.78 <0.008 1 100 Serotyping The PAT tests of the preceding section indicated 3 or 4 strains had pili carrying only one determinant. This was confirmed by running sera derived from pili of four selected strains against the corresponding pili. The results are set forth in the Table below. The maximum response has been normalized to 100 to adjust for the different titres.
Pili Antisera Pittsburgh 3-2 CDC M-2 CDC Pittsburgh Antigenic Determinant T-2 4-2 Pittsburgh 3-2 100 3 2 1 a CDC M-2 3 100 1 2 b CDC T-2 0.4 2 100 2 c Pittsburgh 4-2 2 2 1 100 a Serotyping of Strains of Unknown Determinant Composition Pili are grown from the strains under test and run against antisera against the pi^i carrying the single and g. determinants a, b, c,dte, f / In the PAT Test the pili showed agglutination with one or more single determinants 2o as shown in the Table below.
Strain Serotype Pittsburgh 3-2 a -- - CDC M-2 - b - - CDC T-2 -- c - Pittsburgh 4-2 ---d Norfolk 7-2 ---d CDC B-2 - b - - Pittsburgh 6-2 - b - - CDC C-2 - " - * e CDC 005-2 a b c a Norfolk 2-2 Seattle 1-2 - - c Seattle 3-2 a - - Dayton 8-2 -bed Atlanta 4-2 - b - - Atlanta 6-2 - b - Atlanta 10-2 a b - Atlanta 9-2 - b - d CDC 339-2 Haemoagglutination by GC Pili Preparations General Methods Type 0 human blood containing EDTA as anticoagulant was obtained from a blood bank. Red Blood cells were freshly prepared by washing an aliquot of blood 4 times with 15 volumes of pH 7.3,0.01 M phosphate-buffered saline, and making a 3% (by volume) suspension in the same buffer.
Solutions of 1.0 mg/ml Pittsburgh 3-2 and CDCM-2 pili were made up using the ultraviolet absorbance of the preparations at 280 nm, corrected for scattering, as a measure of concentration. Aliquots (50λ) of the 1.0 mg/ ml solutions of pili'are placed in the first well of a ϋ-bottom Cooke Microtitre plate, 25 λ of Tris-buffered saline + 0.02% azide in all other wells, and the pili diluted with a 25 λ hand operated micro diluter out through the 12th well. - 55 44448 Tris buffered saline or saline (25λ) and 25λ 3% red blood cell suspension is added to each test well, the plate agitated gently to mix, and placed at 4°C. Results are read after 1-2 hours with the aid of a light box.
Results The degrees of haanoagglutinatian observed are: even red color 5+ 4+ No cell pellet or clumps; in well Trace of cell pellet 10 3+ Small cell pellet with very distinct fringe of cell clumps 2+ Distinct cell pellet with moderate number of clumps a fringe of + Distinct cell pellet with a few clumps 15 up the sides of the well.
Titres for both CDCM-2 and Pittsburgh 3-2 pili were done on two different occasions and are shown in the Table below and constitute control tests. - 56 44448 fl) 'H o Zj φ 4J id 3 4) i £ CnMd h rc fl) 0 en β Q tn < fl U rd C C NH •rt Ο I 8) lu Ο X 3 Φ 4J 0 Um 3 -H' tn 0 .-( JJ^1 0 tn ns Q Oi C < s CN e *— >* B ·—. >>· in B *«iGO S >σ\ CM B *— *3· B Γ— E ·%. >E >p— :glutination results CU r-l □ CN • 3 1 υ cn C C! Ο M u 2j *W «rt 5 0 «Ρ tf rt fl) C Ε-» 0) «Η W μ +> tf &) 3 H W H Cu Q en C-n CN H Ο I *rt - CM rd < ι ·Η cn cu Cd I rt £ *d Ό H r-l C -< β rt o rt rt • r-l 6 .rl QJ lU O CU 3 E ίο m •σ E **» >in + cn E ·*>· co S > sr > E *>. ?m E >6 -χ. >· >· E *CM E ·—. ϊvO >4 oo r— Cd a >iO o e >B --. > m ~ 57 Inhibition of Haemoagglutination Removal of Ab-Ag Complex from Antiserum-Pili Mixtures before Titering for Haemoagglutination Methods; To eliminate background Haemoagglutination by sera alone 0.1 ml of undiluted washed red blood cells (RBCs) were added to 1 ml portions of antisera in glass round-bottom centrifuge tubes. The tubes were capped tightly With parafilm and placed upright in a rack on a Yankee Rotator at 4°C. After 1 hour-10 minutes, the sera were spun at 2400 rpm in a refrigerated International Centrifuge, and tested for Haemoagglutiniion ability. The sera were further clarified by centrifugation at 12,000 G in a Sorvall RC-2 centrifuge.
Adsorption of background Haemoagglutination factors at various dilutions pre and post RBC treatment of the antiserum is summarized in the following Table.
Serum Pre- PostWell Dilution Adsorption Adsorption 1 1/2 4+ 2+ 2 1/4 3+ + 3 1/8 3+ + 4 1/16 3+ 0 5 1/32 2+ 0 6 1/54 + 0 7 1/128 0 8 1/256 0 9 1/512 0 10 ‘ 1/1024 0 11 1/2048 0 12 1/4096 0 - 5b 4 4 4 4 3 Removal of Ab-Ag Complexes: Serial dilutions of RBC-adsorbed rabbit preimmune and anti-CDCM-2 sera prepared as above were made in saline. Aliquots (0.1 ml) of each dilution were added to 0.1 ml of ΙΟΟγ/ml M-2 pili in 1.5 ml Microfuge tubes. The tubes were incubated upright on a Yankee Rotator for 1 hour at 37°C. They were then spun 1 minute in the Beckman Microfuge, Slightly over half of the supernatant was removed and 501 of each antiserum dilution placed in each of 2 wells of a Microtitre plate. A 25λ aliquot of 3% RBCs in phosphate buffered saline was added, the plate gently agitated to mix and left at 4° for 1 hour.
The results are set forth in the Table below.
Where in place of CDC-M-2 pili other pili are utilized, similar results are obtained with sera containing antibodies against said pili.
Cone, of Serum Against .CDCM.^2..Rili During Incubation With Hasno’-agglutination Titres In 50 γ/ml M-2 Pili Duplicate Rows G H 1/10 •Ι- + 1/20 Ο 0 1/40 0 0 1/80 + + 1/160 + + 1/320 2+ 2+ 1/640 3+ 3+ 1/1280 2+ 2+ 1/2560 2+ 2+ 1/10 Pre-Iramune Rabbit 2+/3+ 2+/3+ *Note that the Anti CDCM-2 Serum Alone has a + Haemoagglutination at 1/8 Dilution Human Test T2 PJlus crystal from Pittsburgh 3-2 organisms were prepared, preserved with O.Gll .aezthiolatv and emulsified with Freund's incomplete adjuvant. Human male volunteer test subjects were injected with the pilus suspension. Subject B received three 'injections of 2.2 pg/kg, .2.2 pg/Kg and 55 pg/Kg at intervals of 2 weeks. Subject R received three injections of 11 pg/Kg, 11 pg/Kg and 55 pg/Kg at the same intervals. The PAT titres of both subjects rose to 100 after the first injection and to over 200 over the next months.
The subjects were challenged by the intraurethral introduction of a predetermined number of organisms of the same strain, the virulence of which had been previously tested. The same organism was administered to three unimmunized control subjects - T, S and M.
The test results are set forth in the Table below: Resisting and Infecting Doses of Pittsburgh 3-2 Gonococci for Pilus-Immunized and Nen-Immunized Human Subjects 4 Original Subjects *Immunized Infectious Dose Subjects Infected Subjects Resisting 8 χ 101 T B*, R*, S 3 χ 102 B*, R*, S 8 x IO2 S Β* , R* 3 x 104 Β* , R* additional subject X 10-1- M x 102 M x 102 M χ 1θ3 M U448 In accordance with the above procedures, in place of merely using pili with a single determinant a composite dose of pili carrying all determinants may be used.
Analysis of Results Probability analysis of the foregoing results shows that the IDjq of a nonimmune subject is 50 x 10^ organisms and 2.0 x 10^ for immune subjects.
Other experimental work has shown the probability IQ of a male being infected by an infected female is about 30% caused by about 250 organisms being introduced into the male urethral tract during intercourse.
The results of the tests of the present invention indicate that the probability of infection of a male by an infected female during intercourse falls from 30% to 0.86% as a result of immunization to a PAT titer of 100 to 200.

Claims (21)

1. A crystalline' material, derived from pili of Type Tj_ cultures of N. Gonorrhoeae, said crystalline material being soluble in aqueous buffer above pH 8.6 and insoluble below pH 7.7, and- showing strong agglutination against sera containing antibodies against pili derived from at least one of the following strains of Ν, Gonorrhoeae; those designated Pittsburgh 3—2 (ATCC 31149), CDCT—2 (ATCC 31150), CDCM— 2 (ATCC 31148) , Pittsburg 4—2 (ATCC 31151), CDCC—2 (ATCC 31207), Norfolk 2—2 (ATCC 31208) , and CDC 339—2 (ATCC 31206).
2. A crystalline material derived from the pili of Type T 2 cultures of N. Gonorrhoeae, said crystalline material being soluble in aqueous buffer above pH 9,2 and insoluble below pH 8.7, and showing strong agglutination against sera containing antibodies against pili derived from at least one of the following strains of N. Gonorrhoeae; those designated Pittsburgh3—2 (ATCC 31149) , CDCT—2 (ATCC 31150), CDCM—2 (ATCC 31148) , Pittsburgh 4—2 (ATCC 31151) , CDCC—2 (ATCC 31207) , Norfolk 2—2 (ATCC 31208), and CDC 339—2 (ATCC 31206).
3. A material showing strong agglutination against sera containing antibodies against pili derived from at least one of the following strains of N. Gonorrhoeae: those designated Pittsburgh 3—2 (ATCC 31149), CDCT—2 (ATCC 31150), CDCM—2 (ATCC 31148) , Pittsburgh 4—2 (ATCC 31151) CDCC—2 (ATCC 31207), Norfolk 2—2 (ATCC 31208), and CDC 339—2 (ATCC 31206) and whioh has the appearance of single rods in an electromicroscope and a-sedimentation rate of about 37 S at pH 10.1 in ethanolamine buffer, the said rods having a diameter of about 83.4 + 2.3 S.
4. T 2 Gonococcal pilin, being a phosphoglycoprotein isolatable from pili of cultures of Type T 2 N. Gonorrhoeae, said phosphoglycoprotein being a peptide chain of 200 + 9 amino acids having between 2 and 3 phosphate groups and between 1 and 2 hexose sugars covalently bound to said chain, said chain having a molecular weight of 21,500 + 1000 daltons, being substantially soluble in aqueous media at pH values greater than 10.1 and substantially insoluble in aqueous media at pH values less than 8.6, at 20°C.
5. T^ Gonococcal pilin, being a phosphoglycoprotein isolatable from pili of cultures of Type T^ N. Gonorrhoeae, said phosphoglycoprotein being a peptide chain of 200 + 9 amino acids having between 2 and 3 phosphate groups and between 1 and 2 hexose sugars covalently bound to said chain, said chain having a molecular weight of 22,000 + 1000 daltons, being substantially soltble in aqueous media at pH values greater than 8.5 and substantially insoluble in aqueous media at pH values less than 7.7, at 20°C.
6. A method of isolating gonococcal pilin as defined in Claim 4 or Claim 5 which comprises subjecting pili of N. Gonorrhoeae to gel electrophoresis and removing from said gel the major fraction stainable by Coomassie Blue.
7. A composition consisting substantially of at least 92% of T^ or T 2 gonococcal pilin as defined in Claim 4 or Claim 5 and between 6 and 8% of a protein derived from the pili of cultures of Type T^ or T 2 N. Gonorrhoeae and having a molecular weight of about 28,000 daltons, said composition being dissociable into single rods consisting of said protein and said gonococcal pilin at a pH above pH 9.3, the rods having a sedimentation rate of about 37 S at pH 10.1 in ethanolamine and having a diameter of 83.4 + 2.3 8.
8. A composition according to Claim 7 which is a crystalline composition. - 63 4''44< 8
9. A composition according to Claim 7 or Claim. 8 wherein the single rods have a density at pH 10.1 of 1.35 to 1.33 g/ml.
10. A composition according to any one of olaims 7 to 9 and including T 2 gonococcal pilin wherein the ratio of amirp acids in said composition is: aspartic + asparagine 26 ' 7 ; isoleucine 9 alanine 23 arginine 8 glutamic + glutamine . 21 tyrosine 7 lysine 20 proline 6 glycine 17. tryptophan 4—! valine 17 histidine 3 serine 14 1/2 crystine .- 2 leucine 12 methionine 2 threonine g phenylalanine 2 11. A vaccine composition including material derived from gonococcal pili which is substantially free of cells or cell debris and a pharmaceutically acceptable medium for subcutaneous or intramuscular injection, the material showing strong agglutination against sera containing antibodies against pili derived from at least one of the following strains of N. Gonorrhoeae: those designated Pittsburgh 3—2 (ATCC 31149), CDCT—2 (ATCC 31150), CDCM— 2 (ATCC 31148), Pittsburgh 4—2 (ATCC 31151), CDCC—2 (ATCC 31207), Norfolk 2—2 (ATCC 31208), and CDC 339—2 (ATCC 31206).
11. 12. A vaccine composition including a material according to Claim 1, Claim 2 or Claim 3, gonococcal pilin according to Claim 4 or Claim 5 or a composition according to any one of Claims 7 to 10 and a pharmaceutically acceptable medium for intramuscular or subcutaneous injection. - 64 44448
12. 13. A method of testing for the presence of antibodies of N. Gonorrhoeae pili comprising the steps, carried out in vitro, of: (a) treating gonococcal pilus crystals or single rod gonococcal pili with a sample of serum suspected of containing said antibodies thereto, and ( b) observing the occurrence of agglutination of said crystals or said rods, the presence of said agglutination indicating the presence of the antibodies in the serum.
13. 14. A method according to Claim 13 wherein the agglutination is observed with a dark field microscope.
14.
15. A method according to Claim 13 or Claim 14 including the steps of diluting the serum with predetermined amounts of an immunologically inactive diluent and determining the dilution at which no observable agglutination occurs in order to determine relative concentrations of antibodies of the serum.
16. A method according to Claim 15 wherein the diluent is tris or phosphate-buffered saline of pH between pH 7.0 and pH 8.0.
17. A method of testing for the presence of predetermined determinants on antibodies against pili of N. Gonorrhoeae in blood fluids suspected of containing such antibodies, said blood fluids being free of red blood cells, be means of agglutination inhibition comprising the steps, carried out in vitro, of: (a) charging a predetermined amount of said blood fluid to an aqueous medium containing pili of N. Gonorrhoeae bearing predetermined antigenic determinants, (b) incubating the mixture of step (a) to form a precipitate and supernate, (c) separating the precipitate from the supernate, (d) mixing said supernate with a charge of washed red 4444® blood cells and incubating said mixture wherein the presence of unagglutinated sedimented red blood cells indicates the presence of antibody determinants in the blood fluids corresponding to correlated antigenic determinants on the pili. 5
18. A vaccine composition according to Claim 11 substantially as herein described.
19. A method of testing for the presence of antibodies to N. Gonorrhoeae pili according to Claim 13, substantially as herein described. 10
20. A method of testing for the presence of predetermined determinants of antibodies against pili of N. Gonorrhoeae according to Claim 17, substantially as herein described.
21. A composition comprising pilic material derived frcm N. Gonorrhoeae, which is substantially free of cells or cell debris and which shows 15 strong agglutination against sera containing antibodies against pili derived from at least one of the strains of N. Gonorrhoeae designated Pittsburgh 3—2 (ATCC 31149), CDCT—2 (ATCC 31150), COCM—2 (ATCC 31148) and Pittsburgh 4—2 (ATCC 31151).
IE864/76A 1975-04-25 1976-04-23 Gonococcal pili processes for the preparation thereof and the use thereof IE44448B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57120075A 1975-04-25 1975-04-25

Publications (2)

Publication Number Publication Date
IE44448L IE44448L (en) 1976-10-25
IE44448B1 true IE44448B1 (en) 1981-12-02

Family

ID=24282722

Family Applications (1)

Application Number Title Priority Date Filing Date
IE864/76A IE44448B1 (en) 1975-04-25 1976-04-23 Gonococcal pili processes for the preparation thereof and the use thereof

Country Status (14)

Country Link
JP (1) JPS51130525A (en)
AU (1) AU509621B2 (en)
BE (1) BE841068A (en)
CA (1) CA1050423A (en)
CH (1) CH634923A5 (en)
DE (1) DE2617870A1 (en)
ES (1) ES447313A1 (en)
FR (1) FR2308377A1 (en)
GB (1) GB1549345A (en)
HU (1) HU174887B (en)
IE (1) IE44448B1 (en)
IL (1) IL49459A (en)
NL (1) NL7604311A (en)
ZA (1) ZA762438B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237115A (en) * 1977-11-23 1980-12-02 Bactex, Inc. Method of immunization against enterotoxogenic infection by Escherichia coli
US4203971A (en) * 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4454117A (en) * 1980-09-15 1984-06-12 Bactex, Inc. Immunization against infection by Escherichia coli
EP0049945A3 (en) * 1980-09-15 1982-12-01 Bactex Incorporated Determining a hierarchy of piliated organisms and a vaccine prepared from such organisms
DK219084D0 (en) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg ANTIGEN
US5132205A (en) * 1988-10-07 1992-07-21 Eastman Kodak Company High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
KR20010043105A (en) * 1998-04-29 2001-05-25 윌리암 에이취 캘넌, 에곤 이 버그 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease

Also Published As

Publication number Publication date
BE841068A (en) 1976-10-25
DE2617870A1 (en) 1976-12-30
IL49459A0 (en) 1976-06-30
HU174887B (en) 1980-04-28
JPS51130525A (en) 1976-11-12
AU1332176A (en) 1977-10-27
ZA762438B (en) 1978-03-29
CA1050423A (en) 1979-03-13
ES447313A1 (en) 1977-10-16
IL49459A (en) 1980-02-29
IE44448L (en) 1976-10-25
NL7604311A (en) 1976-10-27
CH634923A5 (en) 1983-02-28
JPH0118080B2 (en) 1989-04-03
AU509621B2 (en) 1980-05-22
FR2308377A1 (en) 1976-11-19
DE2617870C2 (en) 1988-09-22
FR2308377B1 (en) 1979-04-06
GB1549345A (en) 1979-08-08

Similar Documents

Publication Publication Date Title
Verwey A type-specific antigenic protein derived from the Staphylococcus
Raistrick et al. Immunizing fractions isolated from Bact. aertrycke
Gotschlich et al. Human immunity to the meningococcus: III. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides
Crumpton et al. An antigenic analysis of Pasteurella pestis by diffusion of antigens and antibodies in agar
US4029756A (en) Serological procedure for determining presence of neisseria gonorrhoeae antibodies
CA1045031A (en) Serological test for gonorrheal antibodies
Beiser et al. Immunochemical Studies on Blood Groups: XII. Preparation of Blood Group Substances from Bovine Stomach Linings and a Comparison of Their Chemical and Immunochemical Properties with Those of Blood Group Substances from Other Species
CA1121723A (en) Neisseria gonorrhoeae heat stable l-antigen purified of proteins and carbohydrates
Fujita et al. Enzyme-linked immunosorbent assay measurement of fluctuations in antibody titer and antigenemia in cancer patients with and without candidiasis
Hollingdale et al. The antigens of Mycoplasma hominis
IE44448B1 (en) Gonococcal pili processes for the preparation thereof and the use thereof
US4696896A (en) Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
US4461838A (en) Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
US3636192A (en) Meningococcal polysaccharide vaccines
Evans-Jones et al. Comparative study of group A and group C meningococcal infection.
IE47149B1 (en) Vaccine
WO1992019970A1 (en) Methods to detect and treat diseases caused by bacterial allergens
Bombardieri et al. An evaluation of an agar gel diffusion test with crude and purified antigens in the diagnosis of hydatid disease
Meister et al. Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split products
Casper The preparation of the type-specific carbohydrates of gonococci
US4186182A (en) Serological test for Neisseria gonorrhoeae antibodies
Henderson Experiments with the Vi Antigen of Bact. typhosum and with Two New Antigenic Substances extracted from Strains of this Organism
Schmidt Cardiolipin AntigenIII. An Examination of Specificity
WO2009132484A1 (en) Lytic proteins of vero cell, preparation method thereof and detection kit for vero hcp comprising the same
RU2188036C1 (en) Method for obtaining erythrocytic antigenic glanderous diagnostic kit